Content area

Abstract

Gadolinium-based contrast agents (GBCA) are essential for diagnostic MRI examinations. GBCA are only used in small quantities on a per-patient basis; however, the acquisition of contrast-enhanced MRI examinations worldwide results in the use of many thousands of litres of GBCA per year. Data shows that these GBCA are present in sewage water, surface water, and drinking water in many regions of the world. Therefore, there is growing concern regarding the environmental impact of GBCA because of their ubiquitous presence in the aquatic environment. To address the problem of GBCA in the water system as a whole, collaboration is necessary between all stakeholders, including the producers of GBCA, medical professionals and importantly, the consumers of drinking water, i.e. the patients. This paper aims to make healthcare professionals aware of the opportunity to take the lead in making informed decisions about the use of GBCA and provides an overview of the different options for action.

In this paper, we first provide a summary on the metabolism and clinical use of GBCA, then the environmental fate and observations of GBCA, followed by measures to reduce the use of GBCA. The environmental impact of GBCA can be reduced by (1) measures focusing on the application of GBCA by means of weight-based contrast volume reduction, GBCA with higher relaxivity per mmol of Gd, contrast-enhancing sequences, and post-processing; and (2) measures that reduce the waste of GBCA, including the use of bulk packaging and collecting residues of GBCA at the point of application.

Critical relevance statement This review aims to make healthcare professionals aware of the environmental impact of GBCA and the opportunity for them to take the lead in making informed decisions about GBCA use and the different options to reduce its environmental burden.

Key points

• Gadolinium-based contrast agents are found in sources of drinking water and constitute an environmental risk.

• Radiologists have a wide spectrum of options to reduce GBCA use without compromising diagnostic quality.

• Radiology can become more sustainable by adopting such measures in clinical practice.

Details

1009240
Title
Review of strategies to reduce the contamination of the water environment by gadolinium-based contrast agents
Author
Dekker, Helena M. 1   VIAFID ORCID Logo  ; Stroomberg, Gerard J. 2 ; Van der Molen, Aart J. 3 ; Prokop, Mathias 1 

 Radboud University Medical Center, Department of Medical Imaging, Nijmegen, The Netherlands (GRID:grid.10417.33) (ISNI:0000 0004 0444 9382) 
 RIWA-Rijn – Association of River Water Works, Nieuwegein, The Netherlands (GRID:grid.10417.33) 
 Leiden University Medical Center, Department of Radiology, Leiden, The Netherlands (GRID:grid.10419.3d) (ISNI:0000 0000 8945 2978) 
Publication title
Volume
15
Issue
1
Pages
62
Publication year
2024
Publication date
Dec 2024
Publisher
Springer Nature B.V.
Place of publication
Heidelberg
Country of publication
Netherlands
e-ISSN
18694101
Source type
Scholarly Journal
Language of publication
English
Document type
Journal Article
Publication history
 
 
Online publication date
2024-02-27
Milestone dates
2024-01-24 (Registration); 2023-09-14 (Received); 2024-01-19 (Accepted)
Publication history
 
 
   First posting date
27 Feb 2024
ProQuest document ID
2938257053
Document URL
https://www.proquest.com/scholarly-journals/review-strategies-reduce-contamination-water/docview/2938257053/se-2?accountid=208611
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Last updated
2024-08-27
Database
ProQuest One Academic